Seth Klarman - Baupost Group

Holding/activity history for  Keryx Biopharmaceuticals Inc. (KERX)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2017   Q2 25,791,678 2.14 $7.23
2017   Q1 25,791,678 1.88 $6.16
2016   Q4 25,791,678 1.99 $5.86
2016   Q3 25,791,678 1.96 $5.31
2016   Q2 25,791,678 2.33 $6.62
2016   Q1 25,791,678 1.75 $4.67
2015   Q4 25,791,678 2.39 $5.05
2015   Q3 25,791,678 1.42 $3.28
2015   Q2 25,791,678 4.35 Add 15.24% 0.58 $9.98
2015   Q1 22,380,200 4.91 Add 22.30% 0.90 $12.73
2014   Q4 18,300,000 5.23 $14.15
2014   Q3 18,300,000 4.50 Add 73.62% 1.91 $13.75
2014   Q2 10,539,986 2.68 Add 67.01% 1.08 $15.38
2014   Q1 6,310,850 2.65 Buy 2.65 $17.04